Iovanace Biotherapeutics (IOVA) PT Lowered to $35 at Piper Sandler
Tweet
Share
E-mailGet Alerts IOVA Hot Sheet
Price: $11.00 +1.85%
Rating Summary:
9 Buy, 6 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 5 | New: 19
Rating Summary:
9 Buy, 6 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 5 | New: 19
Join SI Premium – FREE
Piper Sandler analyst Joseph Catanzaro lowered the price target on Iovanace Biotherapeutics (NASDAQ: IOVA) to $35.00 (from $45.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Goldman Sachs Assumes Iovanace Biotherapeutics (IOVA) at Buy
- Wipro Ltd. (WPRO:IN) (WIT) PT Lowered to INR140 at Citi
- Akamai Technologies (AKAM) PT Raised to $149 at TD Cowen
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
